vimarsana.com

Cadila Healthcare Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zydus Lifesciences introduces new drug in US markets

According to IQVIA MAT data, Mirabegron extended-release tablets (USP 25mg and 50mg) had yearly sales of USD 2.42 billion in the United States.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.